CannTrust (CNTTF) Stock Price, News & Analysis

Company Overview

CannTrust Holdings Inc. is a Canadian cannabis company engaged in the cultivation, production and sale of medical and adult-use cannabis products. Founded in 2013 and headquartered in Vaughan, Ontario, the company has developed integrated greenhouse and indoor growing facilities to support its product portfolio. CannTrust focuses on research-driven cultivation methods and quality assurance protocols to ensure consistency and safety across all product lines.

The company’s offerings include dried flower, pre-rolled products, cannabis oils, softgel capsules, vapourizer cartridges and a range of extraction-based formulations. CannTrust operates an in-house extraction team and formulation laboratory that develops novel cannabinoid and terpene profiles for both patient and recreational markets. The company also provides white-label and contract manufacturing services, leveraging its scalable infrastructure to serve licensed distributors and retail partners in Canada.

While its primary market remains Canada, CannTrust has strategically expanded its presence in international medical markets through export agreements and distribution partnerships. The company holds licences to supply medical cannabis to jurisdictions in Europe, Latin America and Australia, and maintains a listing on the OTC Markets (OTCMKTS:CNTTF) for U.S. investors. This global footprint is supported by a network of compliance and regulatory affairs specialists who monitor evolving cannabis legislation and market requirements.

CannTrust is led by a management team with deep experience in finance, life sciences and consumer goods, under the direction of Chief Executive Officer Peter Aceto and a board of directors chaired by Mark Sandler. Emphasizing governance, sustainability and long-term growth, the company continues to invest in R&D, technology enhancements and strategic partnerships aimed at advancing its product innovation and operational efficiency.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 1.43 million shs
• Average Volume: 528,025 shs
• Market Capitalization: $1.01 billion
• P/E Ratio: 137.18
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CNTTF Stock Analysis - Frequently Asked Questions

How do I buy shares of CannTrust?

Shares of CNTTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Pharmaceutical Preparations
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:CNTTF
• CIK: N/A
• Web: canntrust.ca
• Phone: 64-7872-2300
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 137.18
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $15.96 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 105,608,000
• Free Float: N/A
• Market Cap: $1.01 billion
• Optionable: Not Optionable
• Beta: 4.52